Ricky Kue1, Paul Brown, Chyrl Ness, James Scheulen. 1. Lifeline Ground and Air Critical Care Transportation Services, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. KUE@bostonems.org
Abstract
BACKGROUND: Caring for patients during intrahospital transport is a high-risk activity. Few data exist on the use of specialized transport teams similar to the teams used for out-of-hospital transport. OBJECTIVE: To describe the experience with a dedicated, intra-hospital transport program, to report the rate of clinically significant adverse events, and to examine types of adverse events, interventions provided, and outcomes. METHODS: Patient transports within an academic quaternary-care hospital from November 2007 through April 2008 were retrospectively reviewed. Adverse events were defined as extubation, code team activation, death, sustained arrhythmia, hypoxia exceeding 5 minutes, hypotension exceeding 20% of baseline systolic or diastolic blood pressure and requiring intervention, use of physical restraints, or acute change in mental status. RESULTS: A total of 3383 charts were reviewed (91.8% of all completed transports).The overall rate of adverse events was 1.7% (59 events). Most events were related to hypoxia (25/59) and blood pressure changes (25/59). One extubation and one code team activation occurred. Most interventions involved adjustments to oxygen therapy (22/59) and vasopressor management (18/59). Only 12 (20.3%) of the transports with adverse events were aborted, more often during magnetic resonance imaging (χ(2) = 6.86, df = 1, P = .01) and in older patients (mean [SD], 70.8 [14.2] vs 58.7 [14.9] years; P = .02). CONCLUSIONS: The rate of clinically significant adverse events during patient transport by a specialized team is relatively low. Further studies are needed to compare effectiveness and mortality benefits between intrahospital transport teams and traditional transport teams.
BACKGROUND: Caring for patients during intrahospital transport is a high-risk activity. Few data exist on the use of specialized transport teams similar to the teams used for out-of-hospital transport. OBJECTIVE: To describe the experience with a dedicated, intra-hospital transport program, to report the rate of clinically significant adverse events, and to examine types of adverse events, interventions provided, and outcomes. METHODS:Patient transports within an academic quaternary-care hospital from November 2007 through April 2008 were retrospectively reviewed. Adverse events were defined as extubation, code team activation, death, sustained arrhythmia, hypoxia exceeding 5 minutes, hypotension exceeding 20% of baseline systolic or diastolic blood pressure and requiring intervention, use of physical restraints, or acute change in mental status. RESULTS: A total of 3383 charts were reviewed (91.8% of all completed transports).The overall rate of adverse events was 1.7% (59 events). Most events were related to hypoxia (25/59) and blood pressure changes (25/59). One extubation and one code team activation occurred. Most interventions involved adjustments to oxygen therapy (22/59) and vasopressor management (18/59). Only 12 (20.3%) of the transports with adverse events were aborted, more often during magnetic resonance imaging (χ(2) = 6.86, df = 1, P = .01) and in older patients (mean [SD], 70.8 [14.2] vs 58.7 [14.9] years; P = .02). CONCLUSIONS: The rate of clinically significant adverse events during patient transport by a specialized team is relatively low. Further studies are needed to compare effectiveness and mortality benefits between intrahospital transport teams and traditional transport teams.
Authors: Eddy Fan; Russell D MacDonald; Neill K J Adhikari; Damon C Scales; Randy S Wax; Thomas E Stewart; Niall D Ferguson Journal: Crit Care Date: 2006-02 Impact factor: 9.097
Authors: Marine Aliaga; Jean-Marie Forel; Sophie De Bourmont; Boris Jung; Guillemette Thomas; Martin Mahul; Magali Bisbal; Stephanie Nougaret; Sami Hraiech; Antoine Roch; Kathia Chaumoitre; Samir Jaber; Marc Gainnier; Laurent Papazian Journal: Intensive Care Med Date: 2014-12-18 Impact factor: 17.440
Authors: Erik Jan van Lieshout; Jan Binnekade; Elmer Reussien; Dave Dongelmans; Nicole P Juffermans; Rob J de Haan; Marcus J Schultz; Margreeth B Vroom Journal: Intensive Care Med Date: 2016-05-11 Impact factor: 17.440